Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests
Emerging infectious diseases2009Vol. 15(3), pp. 436–440
Citations Over TimeTop 1% of 2009 papers
Elizabeth A. Hunsperger, Sutee Yoksan, Philippe Buchy, Vinh Chau Nguyen, Shamala Devi Sekaran, Delia Enría, J L Pelegrino, Susana Vázquez, Harvey Artsob, Michael Drebot, Duane J. Gubler, Scott B. Halstead, María G. Guzmán, Harold S. Margolis, Carl-Michael Nathanson, Nidia R. Rizzo Lic, Kovi Bessoff, Srisakul Kliks, Rosanna Ŵ. Peeling
Abstract
Anti-dengue virus immunoglobulin M kits were evaluated. Test sensitivities were 21%-99% and specificities were 77%-98% compared with reference ELISAs. False-positive results were found for patients with malaria or past dengue infections. Three ELISAs showing strong agreement with reference ELISAs will be included in the World Health Organization Bulk Procurement Scheme.
Related Papers
- → Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections(2016)283 cited
- → Elevated levels of total and dengue virus‐specific immunoglobulin E in patients with varying disease severity(2003)74 cited
- → Episodes of the epidemiological factors correlated with prevailing viral infections with dengue virus and molecular characterization of serotype-specific dengue virus circulation in eastern India(2017)25 cited
- → A novel indirect ELISA for diagnosis of dengue fever(2016)19 cited
- → Dengue Virus in the light of Medicinal Plants(2014)